Works matching IS 20457634 AND DT 2022 AND VI 11 AND IP 2

Results: 21

Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 507, doi. 10.1002/cam4.4457

By:

Odani, Satomi;
Tabuchi, Takahiro;
Nakata, Kayo;
Morishima, Toshitaka;
Kuwabara, Yoshihiro;
Koyama, Shihoko;
Kudo, Haruka;
Kato, Mizuki;
Miyashiro, Isao

Publication type:

Article

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 332, doi. 10.1002/cam4.4449

By:

Pizzamiglio, Sara;
Cosentino, Giulia;
Ciniselli, Chiara M.;
De Cecco, Loris;
Cataldo, Alessandra;
Plantamura, Ilaria;
Triulzi, Tiziana;
El‐abed, Sarra;
Wang, Yingbo;
Bajji, Mohammed;
Nuciforo, Paolo;
Huober, Jens;
Ellard, Susan L.;
Rimm, David L.;
Gombos, Andrea;
Daidone, Maria Grazia;
Verderio, Paolo;
Tagliabue, Elda;
Di Cosimo, Serena;
Iorio, Marilena V.

Publication type:

Article

A screening assistance system for cervical cytology of squamous cell atypia based on a two‐step combined CNN algorithm with label smoothing.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 520, doi. 10.1002/cam4.4460

By:

Nambu, Yuta;
Mariya, Tasuku;
Shinkai, Shota;
Umemoto, Mina;
Asanuma, Hiroko;
Sato, Ikuma;
Hirohashi, Yoshihiko;
Torigoe, Toshihiko;
Fujino, Yuichi;
Saito, Tsuyoshi

Publication type:

Article

The prognostic value of TPM1–4 in hepatocellular carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 433, doi. 10.1002/cam4.4453

By:

Tian, Zhihui;
Zhao, Jian;
Wang, Yusheng

Publication type:

Article

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 392, doi. 10.1002/cam4.4458

By:

Yang, Ningning;
Xu, Lu;
Wang, Qingqing;
Chen, Fengxia;
Zhou, Yunfeng

Publication type:

Article

PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 417, doi. 10.1002/cam4.4462

By:

Gion, Yuka;
Doi, Misato;
Nishimura, Yoshito;
Ikeda, Tomoka;
Filiz Nishimura, Midori;
Sakamoto, Misa;
Egusa, Yuria;
Nishikori, Asami;
Fujita, Azusa;
Iwaki, Noriko;
Nakamura, Naoya;
Yoshino, Tadashi;
Sato, Yasuharu

Publication type:

Article

Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC).

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 406, doi. 10.1002/cam4.4461

By:

Tanaka, Kazuyuki;
Tanabe, Hiroki;
Sato, Hiroki;
Ishikawa, Chisato;
Goto, Mitsuru;
Yanagida, Naoyuki;
Akabane, Hiromitsu;
Yokohama, Shiro;
Hasegawa, Kimiharu;
Kitano, Yohei;
Sugiyama, Yuya;
Uehara, Kyoko;
Kobayashi, Yu;
Murakami, Yuki;
Kunogi, Takehito;
Sasaki, Takahiro;
Takahashi, Keitaro;
Ando, Katsuyoshi;
Ueno, Nobuhiro;
Kashima, Shin

Publication type:

Article

Examining the association between oncology drug clinical benefit and the time to public reimbursement.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 380, doi. 10.1002/cam4.4455

By:

Thomson, Sasha;
Everest, Louis;
Witzke, Noah;
Jiao, Tina;
Delos Santos, Seanthel;
Nguyen, Vivian;
Cheung, Matthew C.;
Chan, Kelvin K. W.

Publication type:

Article

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 530, doi. 10.1002/cam4.4459

By:

Mileham, Kathryn F.;
Schenkel, Caroline;
Bruinooge, Suanna S.;
Freeman‐Daily, Janet;
Basu Roy, Upal;
Moore, Amy;
Smith, Robert A.;
Garrett‐Mayer, Elizabeth;
Rosenthal, Lauren;
Garon, Edward B.;
Johnson, Bruce E.;
Osarogiagbon, Raymond U.;
Jalal, Shadia;
Virani, Shamsuddin;
Weber Redman, Mary;
Silvestri, Gerard A.

Publication type:

Article

Cancer‐associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 492, doi. 10.1002/cam4.4452

By:

Brown, Kai M.;
Xue, Aiqun;
Smith, Ross C.;
Samra, Jaswinder S.;
Gill, Anthony J.;
Hugh, Thomas J.

Publication type:

Article

Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451

By:

Pan, Darren;
Kaufman, Jonathan L.;
Htut, Myo;
Agrawal, Manish;
Mazumder, Amitabha;
Cornell, Robert F.;
Zonder, Jeffrey A.;
Fay, Joseph W.;
Modiano, Manuel R.;
Moshier, Erin L.;
Rush, Selena A.;
Tunquist, Brian J.;
Chari, Ajai

Publication type:

Article

Better effect of intrapleural perfusion with hyperthermic chemotherapy by video‐assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 348, doi. 10.1002/cam4.4450

By:

Cao, Yejun;
Zhang, Qiying;
Huang, Zhiyuan;
Chai, Zhengjun;
Liu, Jie;
Wang, Jinyi;
Sun, Zhengliang;
Zhao, Tian;
Wang, Guangxue;
Chen, Guohan;
Han, Yang;
Li, Qinchuan;
Hong, Xuan

Publication type:

Article

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 371, doi. 10.1002/cam4.4454

By:

Hwang, Kihwan;
Kim, Junhyung;
Kang, Seok‐Gu;
Jung, Tae‐Young;
Kim, Jeong Hoon;
Kim, Se‐Hyuk;
Kang, Shin‐Hyuk;
Hong, Yong‐Kil;
Kim, Tae Min;
Kim, Yu Jung;
Choi, Byung Se;
Chang, Jong Hee;
Kim, Chae‐Yong

Publication type:

Article

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 317, doi. 10.1002/cam4.4448

By:

Hou, Gui‐min;
Jiang, Chuang;
Du, Jin‐peng;
Yuan, Ke‐fei

Publication type:

Article

Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 447, doi. 10.1002/cam4.4447

By:

Maslyonkina, Ksenia S.;
Konyukova, Alexandra K.;
Alexeeva, Darya Y.;
Sinelnikov, Mikhail Y.;
Mikhaleva, Liudmila M.

Publication type:

Article

Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 340, doi. 10.1002/cam4.4446

By:

Yao, Shuyang;
Janku, Filip;
Koenig, Kimberly;
Tsimberidou, Apostolia Maria;
Piha‐Paul, Sarina Anne;
Shi, Nai;
Stewart, John;
Johnston, Amanda;
Bomalaski, John;
Meric‐Bernstam, Funda;
Fu, Siqing

Publication type:

Article

B7‐1 and programmed cell death‐ligand 1 in primary and lymph node metastasis lesions of non‐small cell lung carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 479, doi. 10.1002/cam4.4444

By:

Yamada, Takehiro;
Miki, Yasuhiro;
Suzuki, Miho;
Kondoh, Osamu;
Saito‐Koyama, Ryoko;
Ono, Katsuhiko;
Okada, Yoshinori;
Sasano, Hironobu

Publication type:

Article

Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 539, doi. 10.1002/cam4.4443

By:

Li, Zhiyong;
Jiang, Lijuan;
Zhang, Zhiling;
Deng, Minhua;
Wei, Wensu;
Tang, Huancheng;
Guo, Shengjie;
Ye, Yunlin;
Yao, Kai;
Liu, Zhuowei;
Zhou, Fangjian

Publication type:

Article

Muscle weakness as an additional criterion for grading sarcopenia‐related prognosis in patients with cancer.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 308, doi. 10.1002/cam4.4362

By:

Cereda, Emanuele;
Tancredi, Richard;
Klersy, Catherine;
Lobascio, Federica;
Crotti, Silvia;
Masi, Sara;
Cappello, Silvia;
Stobäus, Nicole;
Tank, Maja;
Cutti, Sara;
Arcaini, Luca;
Bonzano, Elisabetta;
Colombo, Sara;
Pedrazzoli, Paolo;
Norman, Kristina;
Caccialanza, Riccardo

Publication type:

Article

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics.

Published in:

Cancer Medicine, 2022, v. 11, n. 2, p. 297, doi. 10.1002/cam4.4084

By:

Chandler, Young;
Schechter, Clyde;
Jayasekera, Jinani;
Isaacs, Claudine;
Kurian, Allison W.;
Cadham, Christopher;
Mandelblatt, Jeanne

Publication type:

Article

Issue Information.

Published in:: Cancer Medicine, 2022, v. 11, n. 2, p. 295, doi. 10.1002/cam4.3989
Publication type:: Article